Blood Res 2020; 55(2): 76-76
Adult T-cell leukemia/lymphoma and Glucose-6-phosphate dehydrogenase deficiency rapidly diagnosed through blood smear examination
Marie de Charette1, Coralie Derrieux2
1Service des Maladies du Sang, Centre Hospitalier Régional Universitaire de Lille, 2Laboratoire d’hématologie, Centre de Biologie Pathologie, Centre Hospitalier Régional Universitaire de Lille, Lille, France
Correspondence to: Coralie Derrieux, Ph.D., Laboratory of Hematology, Lille University Hospital, Professor J. Leclercq Boulevard, Lille 59037, France, E-mail:
Received: March 31, 2020; Revised: April 23, 2020; Accepted: May 11, 2020; Published online: May 20, 2020.
© The Korean Journal of Hematology. All rights reserved.

cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


A 10-year-old girl presented with leukocytosis (199×109/L), anemia (9 g/dL), and thrombocytopenia (34×109/L). After bone marrow (BM) study, she was diagnosed with B-lymphoblastic leukemia with t(4;11)(q21;q23) and KMT2A-AFF1 rearrangement. Following acute lymphoblastic leukemia therapy and early relapse, she participated in a clinical study with daratumumab (anti-CD38 monoclonal antibody).

BM re-evaluation after one treatment cycle showed that 40% of total nucleated cells (TNC) comprised medium blasts with irregular-shaped nucleus, scant basophilic cytoplasm, and similar immunophenotypic characteristics as the B-lymphoblasts during initial diagnosis; however, 56% of TNCs comprised large blasts with abundant cytoplasm and round nucleus. Flow cytometry showed these were similar to monoblasts and positive for CD64, CD4, CD15, and CD33 (A, B, May Grünwald-Giemsa stain, ×600 and ×1,000, respectively; C, monoblasts in blue, lymphoblasts in red). Fluorescence in situ hybridization confirmed KMT2A rearrangement in both populations (D). She was diagnosed with mixed-phenotype acute leukemia with t(4;11)(q21;q23).

Acute leukemia lineage switch is rare and has poor outcome. KMT2A rearrangement is frequently involved because of its relationship with an immature hematopoietic precursor which can be transformed under certain circumstances. This is the first case involving daratumumab. Light microscopy is essential to detect lineage shift.


This Article

Current Issue


SCImago Journal & Country Rank

Indexed/Covered by

Today : 69  /
Total : 368,395